Health Benefits, Pharmacological Effects, Molecular Mechanisms, and Therapeutic Potential of α-Bisabolol

被引:71
作者
Eddin, Lujain Bader [1 ]
Jha, Niraj Kumar [2 ]
Goyal, Sameer N. [3 ]
Agrawal, Yogeeta O. [3 ]
Subramanya, Sandeep B. [4 ,5 ]
Bastaki, Salim M. A. [1 ]
Ojha, Shreesh [1 ,5 ]
机构
[1] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, POB 15551, Al Ain, U Arab Emirates
[2] Sharda Univ, Sch Engn & Technol SET, Dept Biotechnol, Greater Noida 201310, Uttar Pradesh, India
[3] Shri Vile Parle Kelavani Mandals Inst Pharm, Dhule 424001, Maharashtra, India
[4] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Physiol, POB 15551, Al Ain, U Arab Emirates
[5] United Arab Emirates Univ, Zayed Bin Sultan Ctr Hlth Sci, POB 15551, Al Ain, U Arab Emirates
关键词
alpha-Bisabolol; German chamomile tea; natural products; phytochemicals; sesquiterpene; pharmacology; ESSENTIAL OIL COMPOSITION; CHEMICAL-COMPOSITION; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIFUNGAL ACTIVITY; SESQUITERPENE (-)-ALPHA-BISABOLOL; ANTIOXIDANT ACTIVITY; BIOLOGICAL-ACTIVITY; ATOPIC-DERMATITIS; TOPICAL TREATMENT;
D O I
10.3390/nu14071370
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
alpha-Bisabolol is one of the important monocyclic sesquiterpenes, derived naturally from essential oils of many edible and ornamental plants. It was first obtained from Matricaria chamomilla, commonly known as chamomile or German chamomile. The available literature indicates that this plant along with other oc-Bisabolol containing plants is popularly used in traditional medicine for potential health benefits and general wellbeing. Nutritional studies are indicative of the health benefits of alpha-Bisabolol. Numerous experimental studies demonstrated pharmacological properties of alpha-Bisabolol including anticancer, antinociceptive, neuroprotective, cardioprotective, and antimicrobial. This review aims to collectively present different pharmacological activities based on both in vitro and in vivo studies. In the present review using synoptic tables and figures, we comprehensively present that alpha-Bisabolol possesses therapeutic and protective activities, therefore, it can be used for potential health benefits based on pharmacological effects, underlying molecular mechanism, and favorable pharmaceutical properties. Based on the studies mostly performed on cell lines or animal models, it is evident that alpha-Bisabolol may be a promising nutraceutical and phytomedicine to target aberrant biological mechanisms which result in altered physiological processes and various ailments. Given the polypharmacological effects and pleiotropic properties, along with favorable pharmacokinetics, and dietary availability and safety, alpha-Bisabolol can be used as a dietary agent, nutraceutical or phytopharmaceutical agent or as an adjuvant with currently available modern medicines. The regulatory approval of this molecule for use as food additives, and in cosmetics and fragrance industry is also supportive of its human usage. Moreover, further studies are necessary to address pharmaceutical, pharmacological, and toxicological aspects before clinical or nutritional usage in humans. The biological actions and health benefits open opportunities for pharmaceutical development with pharmacological basis of its use in future therapeutics.
引用
收藏
页数:30
相关论文
共 135 条
[1]  
Akbulut H, 2020, DEMIROGLU SCI U FLOR, V4, P23, DOI [10.5606/dsufnjt.2019.004, DOI 10.5606/DSUFNJT.2019.004]
[2]   Composition and antifungal activity of the essential oil from the rhizome and roots of Ferula hermonis [J].
Al-Ja'fari, Abdel-Hadi ;
Vila, Roser ;
Freixa, Blanca ;
Tomi, Felix ;
Casanova, Joseph ;
Costa, Joan ;
Canigueral, Salvador .
PHYTOCHEMISTRY, 2011, 72 (11-12) :1406-1413
[3]   Identification of the Bisabolol Synthase in the Endangered Candeia Tree (Eremanthus erythropappus (DC) McLeisch) [J].
Albertti, Leticia Alves Gomes ;
Delatte, Thierry L. L. ;
de Farias, Katyuce Souza ;
Boaretto, Amanda Galdi ;
Verstappen, Francel ;
van Houwelingen, Adele ;
Cankar, Katarina ;
Carollo, Carlos Alexandre ;
Bouwmeester, Harro J. J. ;
Beekwilder, Jules .
FRONTIERS IN PLANT SCIENCE, 2018, 9
[4]  
Alva M, 2012, NAT PROD COMMUN, V7, P245
[5]   Evaluation of the sesquiterpene (-)-α-bisabolol as a novel peripheral nervous blocker [J].
Alves, Aron de Miranda H. ;
Goncalves, Juan Carlos R. ;
Cruz, Jader Santos ;
Araujo, Demetrius Antonio M. .
NEUROSCIENCE LETTERS, 2010, 472 (01) :11-15
[6]  
Amenu D., 2014, AM J ETHNOMED, V1, P18
[7]   Antimicrobial activity, mechanism of action, and methods for stabilisation of defensins as new therapeutic agents [J].
Amerikova, Meri ;
Pencheva El-Tibi, Ivanka ;
Maslarska, Vania ;
Bozhanov, Stanislav ;
Tachkov, Konstantin .
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2019, 33 (01) :671-682
[8]   Clinical efficacy of new -bisabolol mouthwashes in postoperative complications of maxillofacial surgeries: a randomized, controlled, triple-blind clinical trial [J].
Amora-Silva, Bruno Frota ;
Ribeiro, S. C. ;
Vieira, C. L. ;
Mendes, F. R. ;
Vieira-Neto, A. E. ;
Abdon, A. P. V. ;
Costa, F. N. ;
Campos, A. R. .
CLINICAL ORAL INVESTIGATIONS, 2019, 23 (02) :577-584
[9]   RIFM fragrance ingredient safety assessment, α-bisabolol, CAS registry number 515-69-5 [J].
Api, A. M. ;
Belsito, D. ;
Biserta, S. ;
Botelho, D. ;
Bruze, M. ;
Burton, G. A., Jr. ;
Buschmann, J. ;
Cancellieri, M. A. ;
Dagli, M. L. ;
Date, M. ;
Dekant, W. ;
Deodhar, C. ;
Fryer, A. D. ;
Gadhia, S. ;
Jones, L. ;
Joshi, K. ;
Lapczynski, A. ;
Lavelle, M. ;
Liebler, D. C. ;
Na, M. ;
O'Brien, D. ;
Patel, A. ;
Penning, T. M. ;
Ritacco, G. ;
Rodriguez-Ropero, F. ;
Romine, J. ;
Sadekar, N. ;
Salvito, D. ;
Schultz, T. W. ;
Siddiqi, F. ;
Sipes, I. G. ;
Sullivan, G. ;
Thakkar, Y. ;
Tokura, Y. ;
Tsang, S. .
FOOD AND CHEMICAL TOXICOLOGY, 2020, 141
[10]   Effect of topical heparin and levomenol on atopic dermatitis: a randomized four-arm, placebo-controlled, double-blind clinical study [J].
Arenberger, P. ;
Arenbergerova, M. ;
Drozenova, H. ;
Hladikova, M. ;
Holcova, S. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (06) :688-694